CCL2 exhibited a significant level (~three-fold greater) in skeletal muscle extract of DMD patients compared with BMD and healthy controls; this is further supported by previous studies conducted in animal models showing increased levels of CCL2 in the mdx mouse model in both serum and muscle samples [7,16,26]. The gene discussed is CCL2; the disease is Duchenne muscular dystrophy.